Quick answer : Ketamine may help reduce anhedonia, which is the loss of pleasure, interest, motivation, or emotional reward that commonly occurs with depression. Research suggests that ketamine may improve anhedonia in some people with unipolar or bipolar depression, although it does not work for everyone. For someone who says, “I’m not necessarily sad. I just don’t feel anything anymore,” anhedonia deserves specific attention.
Depression does not always feel like sadness. Some people describe feeling emotionally flat, disconnected, or unable to enjoy things they once loved. They may stop looking forward to spending time with friends, lose interest in hobbies, feel disconnected from their partner, or find that accomplishments no longer feel rewarding.
This symptom is called anhedonia. It refers to a reduced ability to experience pleasure, interest, motivation, or reward and is one of the core symptoms of major depressive disorder. For some patients, anhedonia can persist even when other symptoms of depression begin to improve.
That distinction is important because someone may say that an antidepressant has made them “less depressed” while also saying they still do not feel like themselves.
The brain’s reward system is complex and involves multiple interconnected brain regions and neurotransmitter systems, including dopamine and glutamate. Motivation, anticipation, pleasure, and the ability to learn from rewarding experiences are related but not identical processes.
This may help explain why treating depression does not always restore someone’s ability to experience pleasure. A medication might reduce sadness, anxiety, or negative thinking without fully restoring motivation or emotional engagement.
For patients, that difference can be significant. The goal of treatment is not simply to reduce a depression score. Ideally, treatment should help someone return to relationships, interests, activities, and experiences that make life meaningful.
Ketamine primarily affects the glutamate system, including NMDA and downstream AMPA receptor signaling. These effects appear to influence pathways involved in synaptic plasticity, which is the brain’s ability to modify and strengthen connections between neurons.
Researchers have become increasingly interested in whether these effects may influence the neural circuits involved in reward and motivation. A 2024 systematic review examining 22 studies found improvement in anhedonia following ketamine or esketamine treatment across the included studies, although the authors emphasized limitations in the available evidence, including the relatively small number of placebo-controlled randomized trials.
This does not mean ketamine should be considered a guaranteed treatment for emotional numbness. It does suggest that anhedonia may be an important treatment target in its own right rather than simply another item on a depression questionnaire.
When evaluating depression, we want to know more than whether someone feels sad. We also want to know whether they are beginning to engage with life differently.
A person may notice that music sounds enjoyable again, that they want to call a friend, that exercise feels rewarding, or that they are looking forward to something for the first time in months. Someone who has been emotionally disconnected from family members may notice that affection or connection begins to feel more natural.
These changes can be clinically meaningful even if the person does not wake up one morning feeling completely free of depression.
No. Emotional blunting can occur for different reasons. Depression itself can produce emotional numbness, but trauma, chronic stress, dissociation, substance use, sleep deprivation, and certain medications may also contribute.
Some people taking antidepressants describe emotional blunting even when the medication has reduced other depressive symptoms. This does not mean antidepressants should automatically be discontinued. It does mean that emotional numbness should be discussed specifically rather than assuming it is simply an unavoidable part of depression.
Understanding what is contributing to the symptom can help determine the most appropriate treatment strategy.
Anhedonia can be one of the most disabling and persistent features of depression because it affects the ability to experience motivation, pleasure, connection, and reward. Current research suggests that ketamine may have anti-anhedonic effects in some patients, although more research is needed to understand who is most likely to benefit.
For some people, the most meaningful sign of improvement is not simply, “I feel less depressed.” It is, “I am interested in my life again.”
Anhedonia is a reduced ability to experience pleasure, interest, motivation, or reward. It is a core symptom of major depressive disorder but can also occur with other psychiatric and medical conditions.
Yes. Some people with depression primarily experience emotional numbness, loss of motivation, or inability to enjoy things rather than persistent sadness. This can make depression more difficult to recognize.
Studies have reported improvement in anhedonia following ketamine treatment, sometimes relatively rapidly, but the timing and degree of response vary significantly between individuals. Ketamine does not improve anhedonia in everyone.
